ENVESTNET ASSET MANAGEMENT INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1407543 Berwyn, PA

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$461,370

+$57,513 QoQ

Shares Held

46,137

+8.8% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#164

of 316 holders

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ENVESTNET ASSET MANAGEMENT INC holds $338,809,559 across 34 Drug Manufacturers - Specialty & Generic names. BCRX ranks #22 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	6,276,154	$58,556,516
2	TEVA	Teva Pharmaceutical Industries Ltd	1,702,176	$57,669,722
3	NBIX	Neurocrine Biosciences Inc	262,192	$44,189,839
4	VTRS	Viatris Inc	2,354,974	$37,396,987
5	ZTS	Zoetis Inc.	440,465	$31,651,814
6	TAK	Takeda Pharmaceutical Co Ltd	1,598,174	$25,618,729
7	ELAN	Elanco Animal Health Inc	934,265	$22,992,261
8	UTHR	UNITED THERAPEUTICS Corp	35,362	$19,160,192

All Filings in BCRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$461,370	46,137	+8.8%	Shares	Sole	2026-08-03
2026-03-31	$403,857	42,422	-21.5%	Shares	Sole	2026-05-04
2025-12-31	$421,707	54,065	+82.0%	Shares	Sole	2026-02-10
2025-09-30	$225,521	29,713	+185.7%	Shares	Sole	2025-11-05
2025-06-30	$93,192	10,401	+1.2%	Shares	Sole	2025-08-01
2025-03-31	$77,115	10,282	-0.5%	Shares	Sole	2025-04-29
2024-06-30	$63,870	10,335	-41.9%	Shares	Sole	2024-08-08
2024-03-31	$90,398	17,795	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.